Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | PLOD2 |
| Upstream (Parents) |
|---|
| (<<) ACTN1 → PLOD2 |
| (<<) BMPR2 → PLOD2 |
| (<<) CBFA2T3 → PLOD2 |
| (<<) CD79A → PLOD2 |
| (<<) CYR61 → PLOD2 |
| (<<) EDNRA → PLOD2 |
| (<<) INHBA → PLOD2 |
| (<<) INPP5D → PLOD2 |
| (<<) ITGA5 → PLOD2 |
| (<<) MAL → PLOD2 |
| (<<) MAP3K14 → PLOD2 |
| (<<) NNMT → PLOD2 |
| (<<) PIK3CD → PLOD2 |
| (<<) PIK3R5 → PLOD2 |
| (<<) PLAU → PLOD2 |
| (<<) PLAUR → PLOD2 |
| (<<) PRKCB → PLOD2 |
| (<<) PRKCH → PLOD2 |
| (<<) PTK7 → PLOD2 |
| (<<) PTRF → PLOD2 |
| (<<) RASSF5 → PLOD2 |
| (<<) RYK → PLOD2 |
| (<<) STAT4 → PLOD2 |
| (<<) TRAF1 → PLOD2 |
| (<<) VAV1 → PLOD2 |
| (<<) YWHAE → PLOD2 |
| Downstream (Children) |
|---|
| PLOD2 → APLN (>>) |
| PLOD2 → BRCA1 (>>) |
| PLOD2 → CDH3 (>>) |
| PLOD2 → CEBPA (>>) |
| PLOD2 → COIL (>>) |
| PLOD2 → DNM3 (>>) |
| PLOD2 → DUSP2 (>>) |
| PLOD2 → EMP1 (>>) |
| PLOD2 → FAM136A (>>) |
| PLOD2 → FBXO32 (>>) |
| PLOD2 → FZD3 (>>) |
| PLOD2 → FZD6 (>>) |
| PLOD2 → GNAS (>>) |
| PLOD2 → GNB4 (>>) |
| PLOD2 → GNG12 (>>) |
| PLOD2 → GRB10 (>>) |
| PLOD2 → HS3ST1 (>>) |
| PLOD2 → ITGAE (>>) |
| PLOD2 → LTA4H (>>) |
| PLOD2 → MEF2A (>>) |
| PLOD2 → MT1P2 (>>) |
| PLOD2 → NRIP3 (>>) |
| PLOD2 → PCSK7 (>>) |
| PLOD2 → PDGFB (>>) |
| PLOD2 → PDRG1 (>>) |
| PLOD2 → PIK3C2B (>>) |
| PLOD2 → PLEK2 (>>) |
| PLOD2 → PPP1R3D (>>) |
| PLOD2 → PPP3CB (>>) |
| PLOD2 → PYGL (>>) |
| PLOD2 → RPS28 (>>) |
| PLOD2 → SLC25A37 (>>) |
| PLOD2 → TSPO (>>) |
